PREVALENCE OF CORONARY ARTERY DISEASE IN PATIENTS WITH END STAGE RENAL DISEASE WITH HIGHER CONCENTRATION OF TOTAL HOMOCYSTEINE CONCENTRATION IN BLOOD PLASMA

  • Dr. Ashwini K. Nigam Associate Professor, P G dept. of medicine, S. N. Medical College, Agra, India
  • Dr. Prabhat K. Agrawal Associate Professor, P G dept. of medicine, S. N. Medical College, Agra, India
  • Dr. Subhash Chandra Assistant Professor, P G dept. of medicine, S. N. Medical College, Agra, India
  • Dr. Ashish Gautam Associate Professor, P G dept. of medicine, S. N. Medical College, Agra, India
  • Dr. Jitendra Doneria Lecturer, P G dept. of medicine, S. N. Medical College, Agra, India
Keywords: homocysteine conc., End stage renal disease, coronary artery disease

Abstract

The chronic kidney disease stage 3 to 5 (Glomerular filtration Rate GFR 59 to <15), Renal tubular dysfunction and decreased GFR which leads to decreased renal catabolism of homocysteine. Cardiovascular disease (CVD) is a major cause of death both in general population and in End Stage Renal Disease (ESRD), it accounts approx 40%. An analytical cross-sectional study is designed to find out the prevalence of coronary artery disease in patients with hyperhomocysteinemia in end renal disease patients and to discover the correlation between them. The homocysteine concentrations were found 34.66 ± 1.69 µmol/L and 17.6 ± 1.4 µmol/L for the group of patients with and without evidence of Coronary Artery Disease (CAD) respectively. Whereas the mean homocysteine concentrations of the total population were found 24.8 ± 1.85 µmol/L. This showed that patients having higher values of homocysteine concentration in blood plasma have higher chances of having CAD (p<0.050).

Downloads

Download data is not yet available.

References

1. Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: Global dimension and perspectives. Lancet. 2013;382(9888):260-272. doi:10.1016/S0140-6736(13)60687-X
2. van Guldener C, Stehouwer CDA. Homocysteine metabolism in renal disease. Clin Chem Lab Med. 2003;41(11):1412-1417. doi:10.1515/CCLM.2003.217
3. Liu M, Li X-C, Lu L, et al. Cardiovascular disease and its relationship with chronic kidney disease. Eur Rev Med Pharmacol Sci. 2014;18(19):2918-2926. http://www.ncbi.nlm.nih.gov/pubmed/25339487.
4. Longenecker JC, Coresh J, Powe NR, et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: The CHOICE study. J Am Soc Nephrol. 2002;13(7):1918-1927. doi:10.1097/01.ASN.0000019641.41496.1E
5. Maron BA, Loscalzo J. The Treatment of Hyperhomocysteinemia. Annu Rev Med. 2009;60(1):39-54. doi:10.1146/annurev.med.60.041807.123308
6. Cassar A, Holmes DR, Rihal CS, Gersh BJ. Chronic coronary artery disease: Diagnosis and management. In: Mayo Clinic Proceedings. Vol 84. ; 2009:1130-1146.
doi:10.4065/mcp.2009.0391
7. Vester B, Rasmussen K. High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum. Eur J Clin Chem Clin Biochem. 1991;29(9):549-554.
8. Nygård O, Vollset SE, Refsum H, et al. Total Plasma Homocysteine and Cardiovascular Risk Profile: The Hordaland Homocysteine Study. JAMA J Am Med Assoc.
1995;274(19):1526-1533. doi:10.1001/jama.1995.03530190040032
9. Bernini P, Bertini I, Luchinat C, Nincheri P, Staderini S, Turano P. Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks. J Biomol NMR. 2011;49(3-4):231-243. doi:10.1007/s10858-011-9489-1
10. Mayer EL, Jacobsen DW, Robinson K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol. 1996;27(3):517-527. doi:10.1016/0735-1097(95)00508-0
11. Lee BJ, Lin PT, Liaw YP, Chang SJ, Cheng CH, Huang YC. Homocysteine and risk of coronary artery disease: Folate is the important determinant of plasma homocysteine concentration. Nutrition. 2003;19(7-8):577-583. doi:10.1016/S0899-9007(02)01098-5
How to Cite
1.
Dr. Ashwini K. Nigam, Dr. Prabhat K. Agrawal, Dr. Subhash Chandra, Dr. Ashish Gautam, Dr. Jitendra Doneria. PREVALENCE OF CORONARY ARTERY DISEASE IN PATIENTS WITH END STAGE RENAL DISEASE WITH HIGHER CONCENTRATION OF TOTAL HOMOCYSTEINE CONCENTRATION IN BLOOD PLASMA. Med. res. chronicles [Internet]. 1 [cited 2024Dec.22];5(01):71-7. Available from: https://medrech.com/index.php/medrech/article/view/290
Issue
Vol. 5 No. 01 (2018): Jan-Feb
Section
Original Research Article

Most read articles by the same author(s)